This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Reactive oxygen species (ROS) has been implicated as an important underlying cause in cancer and many neurodegenerative diseases. However, the molecular mechanisms that connect ROS to carcinogenesis and these pathological conditions remain insufficiently understood. This is mainly because most of our current understanding of the effects of ROS has come from indirect endpoint measurements such as DNA, protein damage and lipid peroxidation. These measurements only assess the cumulative effects of ROS and provide limited information on the molecular mechanisms of such effects. We proposed the development of novel fluorescence-based photonic nanosensors capable of direct and selective detection of ROS. We will use the proposed nanosensors to monitor changes in intracellular ROS concentration and distribution directly during carcinogenesis. By correlating these changes to the regulation of key cancer biomarker from parallel bioassays, we hope to further elucidate the differential roles of individual ROS in carcinogenesis and the molecular mechanisms of such roles. To achieve these goals, we have synthesized several potential ROS probes by introducing various benzenesulfonyl groups onto the fluorescein molecule. Unlike traditional ROS probes, these benzenesulfonyl-fluorescein derivatives detect ROS based on non-oxidative mechanisms, rendering selectivity toward different ROS. By varying the type and position of the substituent on the benzenesulfonyl group, the reactivity of the fluorescein derivative can be tuned. The selectivity of these probes toward different ROS is the topic of an on-going study. The outcome of this study will be used in further assisting the design of ROS probes with improved specificity toward individual ROS. We have also prepared amine-modified silica nanoparticles as the nano-platform for the ROS probes. Several parameters were varied in an effort to reduce the size of the nanoparticles and produce nanoparticles with more uniform size. In a proof-of-concept experiment, we successfully incorporated fluorescein isothiocyanate (FITC) onto the amine-modified silica nanoparticles. The feasibility of obtaining functional nanosensors through covalent attachment of benzenesulfonyl-fluorescein-based ROS probes was demonstrated. We plan to use these preliminary results to guide our synthesis of additional ROS probes and conduct more extensive selectivity study. We also plan to evaluate the performance of the nanosensors using a model cell system in the near future.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
2P20RR016456-09
Application #
8168142
Study Section
Special Emphasis Panel (ZRR1-RI-7 (01))
Project Start
2010-07-15
Project End
2011-04-30
Budget Start
2010-07-15
Budget End
2011-04-30
Support Year
9
Fiscal Year
2010
Total Cost
$24,182
Indirect Cost
Name
Louisiana State University A&M Col Baton Rouge
Department
Pathology
Type
Schools of Veterinary Medicine
DUNS #
075050765
City
Baton Rouge
State
LA
Country
United States
Zip Code
70803
Hosain, Salman B; Khiste, Sachin K; Uddin, Mohammad B et al. (2016) Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells. Oncotarget 7:60575-60592
Ibrahim, Sulaimon; Chowriappa, Pradeep; Dua, Sumeet et al. (2015) Classification of diabetes maculopathy images using data-adaptive neuro-fuzzy inference classifier. Med Biol Eng Comput 53:1345-60
Babu, Sainath; Uppu, Sannihith N; Martin, Brittany et al. (2015) Unusually high levels of bisphenol A (BPA) in thermal paper cash register receipts (CRs): development and application of a robust LC-UV method to quantify BPA in CRs. Toxicol Mech Methods 25:410-6
El-Saadi, Madison Wynne; Williams-Hart, Tara; Salvatore, Brian A et al. (2015) Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent. In Silico Pharmacol 3:6
Pogue, A I; Dua, P; Hill, J M et al. (2015) Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice. J Inorg Biochem 152:206-9
Zhang, Cheng; Rissman, Robert A; Feng, June (2015) Characterization of ATP alternations in an Alzheimer's disease transgenic mouse model. J Alzheimers Dis 44:375-8
Gu, Ying; Barzegar, Mansoureh; Chen, Xin et al. (2015) Fusarochromanone-induced reactive oxygen species results in activation of JNK cascade and cell death by inhibiting protein phosphatases 2A and 5. Oncotarget 6:42322-33
Pasluosta, Cristian F; Chiu, Alan W L (2015) Modulation of grasping force in prosthetic hands using neural network-based predictive control. Methods Mol Biol 1260:179-94
Gu, Ying; Chen, Xin; Shang, Chaowei et al. (2014) Fusarochromanone induces G1 cell cycle arrest and apoptosis in COS7 and HEK293 cells. PLoS One 9:e112641
Patwardhan, Gauri A; Hosain, Salman B; Liu, David X et al. (2014) Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells. Biochim Biophys Acta 1841:1571-80

Showing the most recent 10 out of 179 publications